Posts by: Daniela Semedo, PhD

Daniela Semedo, PhD

Daniela holds a PhD in Clinical Psychology from The University of Edinburgh, United Kingdom, a MSc in Health Psychology and a BSc in Clinical Psychology. Her work has been focused on vulnerability to psychopathology and early identification and intervention in psychosis.

November 15, 2016November 15, 2016

Enterprise Therapeutics Closes on $5 Million in Financing to Develop Mucus-clearing Therapies

Asthma, COPD, Cystic Fibrosis, News

Enterprise Therapeutics has closed on £4 million ($5 million U.S.) in financing to develop and advance its novel mucus-clearing therapies to treat patients with severe lung diseases. Enterprise is pursuing new ... Read more

November 7, 2016November 10, 2016

Scientists Find that Smoking a Pack a Day Causes About 150 Mutations in Lung Cells per Year

Lung Cancer, News

Scientists have uncovered the genomic mutations and DNA methylation patterns likely caused by tobacco smoke in 17 types of cancerous tumors. DNA methylation is a mechanism used by cells to control gene ... Read more

November 2, 2016November 2, 2016

Regular Visits to the Dentist Connected to Decreased Risk of Pneumonia

News

Regular visits to the dentist may decrease the risk of pneumonia by reducing mouth bacteria, according to a study presented at IDWeek 2016 Oct. 26-30 in New Orleans. The scientific meeting was attended ... Read more

October 26, 2016October 26, 2016

CF Therapy Candidate Resunab Granted Orphan Designation by European Commission

Cystic Fibrosis, News

The European Commission has granted Orphan Designation to Corbus Pharmaceuticals’ Resunab to treat cystic fibrosis (CF) in the European Union. In the U.S., Resunab was granted both orphan drug and fast track designation as ... Read more

October 21, 2016October 21, 2016

NIH Awards Scientists $5.2M for Lung Regeneration Research

Asthma, Cystic Fibrosis, News

Researchers at the University of Pennsyvania School of Medicine, Cincinnati Children’s Hospital and Boston University were awarded a seven-year, $5.2 million grant to study mechanisms that promote lung regeneration. The grant is from ... Read more

October 17, 2016October 17, 2016

FDA Will Review New Drug Application for SUN-101/eFlow for COPD Treatment

News

The U.S. Food and Drug Administration (FDA) has accepted for review Sunovion’s new drug application (NDA) for its SUN-101/eFlow system as a long-term maintenance therapy for airflow obstruction in adults with chronic obstructive pulmonary ... Read more

October 7, 2016October 7, 2016

NICE Acts to Make Tagrisso Available to Patients in UK with Agressive Lung Cancer

Lung Cancer, News

The National Institute for Health and Care Excellence (NICE) has issued a final draft guidance recommending Tagrisso (osimertinib) be made available within the National Health Service (NHS) in England and Wales to treat a particularly aggressive form ... Read more

October 6, 2016October 6, 2016

Digital App Ensures Adequate Nutrition and Care for Cystic Fibrosis Patients

Cystic Fibrosis, News

Many people with cystic fibrosis (CF) need help to ensure they’re getting adequate nutrition and the correct amount of enzymes, as well as related reminders. As part of the European MyCyFAPP project, researchers are ... Read more

September 29, 2016September 29, 2016

Three-fold Risk of Asthma Attacks Seen in Patients Most Exposed to Volcanic Eruptions in Hawai

Asthma, News

People with asthma, especially children, who are exposed to high levels of sulfur dioxide (SO2) in gases released from the active volcano Kīlauea, in Hawai, are at greater risk of having ... Read more

September 28, 2016September 28, 2016

Specific Mold Toxins Weaken Airways’ Defenses and Immunity, Penn Study Shows

COPD, Cystic Fibrosis, News

Researchers at the Perelman School of Medicine at the University of Pennsylvania found that toxins from a type of mold, called aflatoxins, weaken the airways’ self-clearing mechanisms and immunity, which may ... Read more